ipamorelin clinicaltrials gov CJC-1295 vs. Tesamorelin FDA Approval Status 2026
Description
10.1136/ip.2010.029215.951 20 FlanaganS
Control patients (n = 28) received standard of care treatment only, while NAC patients (n = 28) received the standard of care treatment plus N-acetyl cysteine
Zn deficiency can also affect the neuronal CA but these effects remain to be investigated
Since BSO treatment alone did not suppress the growth of T315I-Bcr-Abl cells, a synergistic effect of JMF4073 in combination with BSO on elimination of these cells was very clear
10.21769/BioProtoc.4188 49
